The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Signatures of mutational processes in human cancer
Open accessAbstract
All cancers are caused by somatic mutations; however, understanding of the biological processes generating these mutations is limited. The catalogue of somatic mutations from a cancer genome bears the signatures of the mutational processes that have been operative. Here we analysed 4,938,362 mutations from 7,042 cancers and extracted more than 20 distinct mutational signatures. Some are present in many cancer types, notably a signature attributed to the APOBEC family of cytidine deaminases, whereas others are confined to a single cancer class. Certain signatures are associated with age of the patient at cancer diagnosis, known mutagenic exposures or defects in DNA maintenance, but many are of cryptic origin. In addition to these genome-wide mutational signatures, hypermutation localized to small genomic regions, 'kataegis', is found in many cancer types. The results reveal the diversity of mutational processes underlying the development of cancer, with potential implications for understanding of cancer aetiology, prevention and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The use of TAA-derived epitopes has the advantage of allowing development of an off-the-shelf product for a tumour indication with low mutational burden such as GBM, where patients’ tumours express only few tumour-specific antigens [38].”
From Preclinical development of an mRNA-based multiepitope immunotherapeutic for glioblastoma (2025) · cites this paper as [38]
Experimental — accuracy not yet measuredIn the citing paper
“In MM, SBS9, associated with mutations introduced by polymerase η repair of activation-induced deaminase (AID) activity26,31,32, was strongly linked with Q61H”
From The origins and genetic interactions of KRAS mutations are allele- and tissue-specific (2021) · cites this paper as [26]
In the citing paper
“Five substitution and five rearrangement signatures [8, 9] were identified”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [8]
In the citing paper
“a high SNV burden associated with APOBEC substitution signature [8]”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [8]
In the citing paper
“It has also been noted that the 'pol h mutational signature' (Signature 9; http://cancer.sanger.ac.uk/cosmic/sig natures) occurs in chronic lymphocytic leukemia and malignant Bcell lymphoma genomes 6,26,27 .”
From DNA polymerase η mutational signatures are found in a variety of different types of cancer (2018) · cites this paper as [6]
In the citing paper
“Several distinct mutational signatures sculpt the genome of NSCLC – including signatures of tobacco exposure and APOBEC-mediated cytidine deamination57.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [57]
In the citing paper
“Melanoma somatic mutations consist almost entirely of C → T transitions, 28% of which are TCC → T mutations (19,31).”
From Evidence for recent, population-specific evolution of the human mutation rate (2015) · cites this paper as [19]
In the citing paper
“Excess C → T transitions are characteristic of several different mutagenic processes including UV damage and cytosine deamination (19).”
From Evidence for recent, population-specific evolution of the human mutation rate (2015) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationStratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Self-citationSomatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Self-citationA landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Self-citationThe Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C. L., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,541
Self-citationThe mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,100
Xue, R., Li, R., Guo, H., Guo, L., Su, Z., Ni, X., Qi, L., Zhang, T., Li, Q., Zhang, Z., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.033 · Cited by 214
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
Gounder, M. M., Agaram, N. P., Trabucco, S. E., Robinson, V. L., Ferraro, R., Millis, S. Z., Krishnan, A., Lee, J., Attia, S., Abida, W. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30496-0 · Cited by 221
Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and CancerPreprint
Laugesen, A., Højfeldt, J. W., & Helin, K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026575 · Cited by 225
Knaus, H. A., Berglund, S., Hackl, H., Blackford, A. L., Zeidner, J. F., Montiel-Esparza, R., Mukhopadhyay, R., Vanura, K., Blazar, B. R., Karp, J. E., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120974 · Cited by 220
The molecular landscape of glioma in patients with Neurofibromatosis 1
D’Angelo, F., Ceccarelli, M., Tala, Garofano, L., Zhang, J., Frattini, V., Caruso, F. P., Lewis, G., Alfaro-Munoz, K. D., Bauchet, L., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0263-8 · Cited by 220
Souroullas, G. P., Jeck, W. R., Parker, J. S., Simon, J. M., Liu, J.-Y., Paulk, J., Xiong, J., Clark, K. S., Fedoriw, Y., Qi, J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4092 · Cited by 212
Lymphatic vessels regulate immune microenvironments in human and murine melanoma
Lund, A. W., Wagner, M., Fankhauser, M., Steinskog, E. S. S., Broggi, M. A. S., Spranger, S., Gajewski, T. F., Alitalo, K. K., Eikesdal, H. P., Wiig, H., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci79434 · Cited by 218
Aging and the rise of somatic cancer-associated mutations in normal tissues
Risques, R. A., & Kennedy, S. R. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007108 · Cited by 219
The pancreatic cancer genome revisited
Hayashi, A., Hong, J., & Iacobuzio-Donahue, C. A. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00463-z · Cited by 211
Taber, A., Christensen, E., Lamy, P., Nordentoft, I., Prip, F., Lindskrog, S. V., Birkenkamp‐Demtröder, K., Okholm, T. L. H., Knudsen, M., Pedersen, J. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18640-0 · Cited by 214
Allgäuer, M., Budczies, J., Christopoulos, P., Endris, V., Lier, A., Rempel, E., Volckmar, A., Kirchner, M., von Winterfeld, M., Leichsenring, J., et al. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.08.14 · Cited by 212
Forschner, A., Battke, F., Hadaschik, D., Schulze, M., Weißgraeber, S., Han, T., Kopp, M., Frick, M., Klumpp, B. D., Tietze, N., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0659-0 · Cited by 215
The genome as a record of environmental exposure
Nik‐Zainal, S., Kucab, J. E., Morganella, S., Głodzik, D., Alexandrov, L. B., Arlt, V. M., Weninger, A., Hollstein, M. C., Stratton, M. R., & Phillips, D. H. (2015) · Mutagenesis · doi:10.1093/mutage/gev073 · Cited by 209
Self-citationHypermutation In Pancreatic Cancer
Humphris, J. L., Patch, A., Nones, K., Bailey, P. J., Johns, A. L., McKay, S., Chang, D. K.-F., Miller, D. K., Pajic, M., Kassahn, K. S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.09.060 · Cited by 209
Self-citationThe genomic landscape of pediatric myelodysplastic syndromes
Schwartz, J. R., Ma, J., Westover, T., Walsh, M. P., Wang, S., Bryant, V. L., Song, G., Wu, G., Easton, J. B., Kesserwan, C. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01590-5 · Cited by 213
van Dessel, L. F., van Riet, J., Smits, M., Zhu, Y., Hamberg, P., van der Heijden, M. S., Bergman, A. M., van Oort, I. M., de Wit, R., Voest, E. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13084-7 · Cited by 214
Mechanism, cellular functions and cancer roles of polymerase-theta-mediated DNA end joining
Ramsden, D. A., Carvajal-Garcia, J., & Gupta, G. P. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00405-2 · Cited by 218
The origins and genetic interactions of KRAS mutations are allele- and tissue-specific
Cook, J. H., Melloni, G. E. M., Gulhan, D. C., Park, P. J., & Haigis, K. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22125-z · Cited by 208
Engineering patient-specific cancer immunotherapies
Scheetz, L., Park, K. S., Li, Q., Lowenstein, P. R., Castro, M. G., Schwendeman, A., & Moon, J. J. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0436-x · Cited by 208
Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse
Garg, M., Nagata, Y., Kanojia, D., Mayakonda, A., Yoshida, K., Keloth, S. H., Zang, Z. J., Okuno, Y., Shiraishi, Y., Chiba, K., et al. (2015) · Blood · doi:10.1182/blood-2015-05-646240 · Cited by 212
Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study
Shi, J., Hua, X., Zhu, B., Ravichandran, S., Wang, M., Nguyen, C. D., Brodie, S. A., Palleschi, A., Alloisio, M., Pariscenti, G., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002162 · Cited by 212
Gao, S., Yan, L., Wang, R., Li, J., Yong, J., Zhou, X., Wei, Y., Wu, X., Wang, X., Fan, X., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0105-4 · Cited by 208
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
Ding, X., He, M., Chan, A. W. H., Song, Q. X., Sze, S. C., Chen, H., Man, K., Man, K., Chan, S. L., Lai, P. B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.09.005 · Cited by 212
Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy
Martínez‐Bosch, N., Vinaixa, J., & Navarro, P. (2018) · Cancers · doi:10.3390/cancers10010006 · Cited by 216
Volckmar, A., Sültmann, H., Riediger, A. L., Fioretos, T., Schirmacher, P., Endris, V., Stenzinger, A., & Dietz, S. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22517 · Cited by 209
Zhang, X., Wang, J., Shao, G., Wang, Q., Qu, X., Wang, B., Moy, C. H., Fan, Y., Albertyn, Z., Huang, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09762-1 · Cited by 210
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model
Schrörs, B., Boegel, S., Albrecht, C. H., Bukur, T., Bukur, V., Holtsträter, C., Ritzel, C., Manninen, K., Tadmor, A. D., Vormehr, M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01195 · Cited by 215
Somatic Evolution in Non-neoplastic IBD-Affected Colon
Ólafsson, S., McIntyre, R. E., Coorens, T. H. H., Butler, T. M., Jung, H., Robinson, P. S., Lee-Six, H., Sanders, M. A., Arestang, K., Dawson, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.036 · Cited by 213
Self-citationSynthetic Lethality in Cancer Therapeutics: The Next Generation
Setton, J. S., Zinda, M. J., Riaz, N., Durocher, D., Zimmermann, M., Koehler, M. T., Reis-Filho, J. S., & Powell, S. N. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1503 · Cited by 214
Macroscopic somatic clonal expansion in morphologically normal human urothelium
Li, R., Du, Y., Chen, Z., Xu, D., Lin, T., Jin, S., Wang, G., Liu, Z., Lu, M., Chen, X., et al. (2020) · Science · doi:10.1126/science.aba7300 · Cited by 206
Anti-GD2 immunotherapy for neuroblastoma
Sait, S. F., & Modak, S. I. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1364995 · Cited by 210
Looi, C.-K., Chung, F. F., Leong, C., Wong, S. F., Rosli, R., & Mai, C. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1153-8 · Cited by 209
Genetic alterations and their clinical implications in DLBCL
Miao, Y., Medeiros, L. J., Li, Y., Li, J., & Young, K. H. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0225-1 · Cited by 208
Lucas, F. A. S., Allenson, K., Bernard, V., Castillo, J., Kim, D. U., Ellis, K. E. S., Ehli, E. A., Davies, G. E., Petersen, J. L., Li, D., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv604 · Cited by 209
Rebuilding Chromosomes After Catastrophe: Emerging Mechanisms of Chromothripsis
Ly, P., & Cleveland, D. W. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.08.005 · Cited by 209
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma
Manier, S., Park, J., Capelletti, M., Bustoros, M. W., Freeman, S. S., Ha, G., Rhoades, J., Liu, C. J., Huynh, D., Reed, S. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04001-5 · Cited by 212
Desbois, M., Udyavar, A. R., Ryner, L. C., Kozlowski, C., Guan, Y., Dürrbaum, M., Lu, S., Fortin, J., Koeppen, H., Ziai, J. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19408-2 · Cited by 209
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
Thomas, R., Al‐Khadairi, G., & Decock, J. V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.600573 · Cited by 209
Reactive oxygen species: Role in carcinogenesis, cancer cell signaling and tumor progression
Sarmiento-Salinas, F. L., Pérez-González, A., Acosta-Casique, A., Ix-Ballote, A., Díaz, A., Treviño, S., Rosas-Murrieta, N. H., Millán-Pérez-Peña, L., & Maycotte, P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119942 · Cited by 211
Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder
Krupp, D. R., Barnard, R. A., Duffourd, Y., Evans, S. A., Mulqueen, R. M., Bernier, R., Rivière, J.-B., Fombonne, E., & O’Roak, B. J. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.07.016 · Cited by 204
Rodrigues, D. N., Rescigno, P., Liu, D., Yuan, W., Carreira, S., Lambros, M. B. K., Seed, G., Mateo, J., Riisnaes, R., Mullane, S. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121924 · Cited by 209
A Deep Learning Framework for Predicting Response to Therapy in Cancer
Sakellaropoulos, T., Vougas, K. N., Narang, S., Koinis, F., Kotsinas, A., Polyzos, A., Moss, T. J., Piha-Paul, S. A., Zhou, H., Kardala, E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.017 · Cited by 207
Clonal hematopoiesis in acquired aplastic anemia
Ogawa, S. (2016) · Blood · doi:10.1182/blood-2016-01-636381 · Cited by 205
Cancer prevention and screening: the next step in the era of precision medicine
Loomans-Kropp, H. A., & Umar, A. (2019) · npj Precision Oncology · doi:10.1038/s41698-018-0075-9 · Cited by 217
Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications
Marino, F. Z., Bianco, R., Accardo, M., Ronchi, A., Cozzolino, I., Morgillo, F., Rossi, G., & Franco, R. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.34739 · Cited by 209
Genomic–transcriptomic evolution in lung cancer and metastasis
Martínez‐Ruiz, C., Black, J. R., Puttick, C., Hill, M. S., Demeulemeester, J., Cadieux, E. L., Thol, K., Jones, T. P., Veeriah, S., Naceur‐Lombardelli, C., et al. (2023) · Nature · doi:10.1038/s41586-023-05706-4 · Cited by 211
Cancer: Evolution Within a Lifetime
Gerlinger, M., McGranahan, N., Dewhurst, S. M., Burrell, R. A., Tomlinson, I. P. M., & Swanton, C. (2014) · Annual Review of Genetics · doi:10.1146/annurev-genet-120213-092314 · Cited by 210
Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma
Liu, X., Zhang, M., Ying, S., Zhang, C., Lin, R., Zheng, J., Zhang, G., Tian, D., Guo, Y., Du, C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.033 · Cited by 203
Nong, J., Gong, Y., Guan, Y., Yi, X., Yi, Y., Chang, L., Yang, L., Lv, J., Guo, Z., Jia, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05327-w · Cited by 202
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
de Jonge, M. M., Auguste, A., van Wijk, L. M., Schouten, P. C., Meijers, M., ter Haar, N. T., Smit, V. T. H. B. M., Nout, R. A., Glaire, M. A., Church, D. N., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1443 · Cited by 202
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
van der Lee, D. I., Reijmers, R. M., Honders, M. W., Hagedoorn, R. S., de Jong, R. C. M., Kester, M. G. D., van der Steen, D. M., de Ru, A. H., Kweekel, C., Bijen, H. M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci97482 · Cited by 207
Fleur, L. L., Falk-Sörqvist, E., Smeds, P., Berglund, A., Sundström, M., Mattsson, J. S., Brandén, E., Koyi, H., Isaksson, J., Brunnström, H., et al. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.01.003 · Cited by 202
Ranki, T., Pesonen, S. A., Hemminki, A., Partanen, K. P. L., Kairemo, K., Alanko, T., Lundin, J. E., Linder, N., Turkki, R., Ristimaki, A. P., et al. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0121-5 · Cited by 204
Kuk, D., Shoushtari, A. N., Barker, C. A., Panageas, K. S., Munhoz, R. R., Momtaz, P., Ariyan, C. E., Brady, M. S., Coit, D. G., Bogatch, K., et al. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0522 · Cited by 204
Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
Molinaro, C., Martoriati, A., Pélinski, L., & Cailliau, K. (2020) · Cancers · doi:10.3390/cancers12102863 · Cited by 205
Three molecular pathways model colorectal carcinogenesis in L ynch syndrome
Ahadova, A., Gallon, R., Gebert, J. F., Ballhausen, A., Endris, V., Kirchner, M., Stenzinger, A., Burn, J., Doeberitz, M. V. K., Bläker, H., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31300 · Cited by 200
TIGIT: a novel immunotherapy target moving from bench to bedside
Solomon, B. L., & Garrido‐Laguna, I. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2246-5 · Cited by 202
Immune-based therapies for hepatocellular carcinoma
Pinato, D. J., Guerra, N., Fessas, P., Murphy, R., Mineo, T., Mauri, F. A., Mukherjee, S. K., Thursz, M. R., Wong, C. N., Sharma, R., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1249-9 · Cited by 202
Pérez-Ruiz, E., Melero, I., Kopecka, J., Sarmento‐Ribeiro, A. B., García‐Aranda, M., & Rivas, J. D. L. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100718 · Cited by 202
Mutant p53: it’s not all one and the same
Kennedy, M. C., & Lowe, S. W. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00989-y · Cited by 211
Chromothripsis: A New Mechanism for Rapid Karyotype Evolution
Leibowitz, M. L., Zhang, C., & Pellman, D. S. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-120213-092228 · Cited by 205
Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes
Perera, D. S., Poulos, R. C., Shah, A., Beck, D., Pimanda, J. E., & Wong, J. W. H. (2016) · Nature · doi:10.1038/nature17437 · Cited by 199
Heppt, M. V., Heinzerling, L., Kähler, K. C., Forschner, A., Kirchberger, M. C., Loquai, C., Meißner, M., Meier, F. E., Terheyden, P. A. M., Schell, B., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.038 · Cited by 202
Clinical and translational advances in esophageal squamous cell carcinoma
Reichenbach, Z. W., Murray, M. G., Saxena, R., Farkas, D. T., Karassik, E. G., Klochkova, A., Patel, K., Tice, C. M., Hall, T. M., Gang, J., et al. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.05.004 · Cited by 198
Molecular and histopathology directed therapy for advanced bladder cancer
Alifrangis, C., McGovern, U., Freeman, A., Powles, T. B., & Linch, M. D. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0208-0 · Cited by 201
Acquired and intrinsic resistance in cancer immunotherapy
Kelderman, S., Schumacher, T. N. M., & Haanen, J. B. A. G. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.011 · Cited by 197
Self-citationVieira, V. C., Leonard, B. C., White, E. A., Starrett, G. J., Temiz, N. A., Lorenz, L. D., Lee, D., Soares, M. A., Lambert, P. F., Howley, P. M., et al. (2014) · mBio · doi:10.1128/mbio.02234-14 · Cited by 197
Clonal evolution of colorectal cancer in IBD
Choi, C.-H. R., Bakir, I. A., Hart, A. L., & Graham, T. A. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.1 · Cited by 202
Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
Feng, Q. F., & He, B. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00858 · Cited by 202
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
Egen, J. G., Ouyang, W., & Wu, L. C. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.010 · Cited by 198
Nanocarriers based on bacterial membrane materials for cancer vaccine delivery
Zhao, X., Zhao, R., & Nie, G. (2022) · Nature Protocols · doi:10.1038/s41596-022-00713-7 · Cited by 198
Geographic and age variations in mutational processes in colorectal cancer
Díaz‐Gay, M., dos Santos, W., Moody, S., Kazachkova, M., Abbasi, A., Steele, C. D., Vangara, R., Senkin, S., Wang, J., Fitzgerald, S., et al. (2025) · Nature · doi:10.1038/s41586-025-09025-8 · Cited by 204
Self-citationExploration of liver cancer genomes
Shibata, T., & Aburatani, H. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.6 · Cited by 202
Self-citationAssociation of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer
Li, X., Pasche, B., Zhang, W., & Chen, K. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2805 · Cited by 197
Zacharakis, N., Huq, L., Seitter, S. J., Kim, S. P., Gartner, J. J., Sindiri, S., Hill, V. K., Li, Y. F., Paria, B. C., Ray, S., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02170 · Cited by 196
Zhang, K., Erkan, E. P., Jamalzadeh, S., Dai, J., Andersson, N., Kaipio, K., Lamminen, T., Mansuri, N., Huhtinen, K., Carpén, O., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm1831 · Cited by 202
Antioxidant and anticancer activities of Moringa oleifera leaves
Charoensin, S. (2014) · Journal of Medicinal Plants Research · doi:10.5897/jmpr2013.5353 · Cited by 195
Punctuated evolution of canonical genomic aberrations in uveal melanoma
Field, M. G., Durante, M. A., Anbunathan, H., CAI, L. Z., Decatur, C. L., Bowcock, A. M., Kurtenbach, S., & Harbour, J. W. (2018) · Nature Communications · doi:10.1038/s41467-017-02428-w · Cited by 198
Li, M., Liu, F., Zhang, F., Zhou, W., Jiang, X., Yang, Y., Qu, K., Wang, Y., Ma, Q., Wang, T., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316039 · Cited by 195
Immune Resistance in Lung Adenocarcinoma
Σπέλλα, Μ., & Stathopoulos, G. T. (2021) · Cancers · doi:10.3390/cancers13030384 · Cited by 196
Ravi, A., Hellmann, M. D., Arniella, M. B., Holton, M., Freeman, S. S., Naranbhai, V., Stewart, C., Leshchiner, I., Kim, J., Akiyama, Y., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01355-5 · Cited by 201
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
Arends, C. M., Galan-Sousa, J., Hoyer, K., Chan, W., Jäger, M., Yoshida, K., Seemann, R., Noerenberg, D., Waldhueter, N., Fleischer-Notter, H., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0047-7 · Cited by 194
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
Kan, Z., Ding, Y., Kim, J.-H., Jung, H. H., Chung, W., Lal, S., Cho, S., Fernandez-Banet, J., Lee, S. K., Kim, S. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04129-4 · Cited by 200
Park, Y., Kuen, D., & Chung, Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0130-1 · Cited by 198
The molecular origin and taxonomy of mucinous ovarian carcinoma
Cheasley, D. A., Wakefield, M. J., Ryland, G. L., Allan, P. E., Alsop, K., Amarasinghe, K. C., Ananda, S. S., Anglesio, M. S., Au‐Yeung, G., Böhm, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11862-x · Cited by 195
van den Berg, J. H., Heemskerk, B., van Rooij, N., Gomez-Eerland, R., Michels, S., van Zon, M., de Boer, R., Bakker, N. A. M., Jorritsma‐Smit, A., van Buuren, M. M., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000848 · Cited by 194
Self-citationGenome-wide kinetics of DNA excision repair in relation to chromatin state and mutagenesis
Adar, S., Hu, J., Lieb, J. D., & Sancar, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603388113 · Cited by 195
The Role of the Estrogen Pathway in the Tumor Microenvironment
Rothenberger, N. J., Somasundaram, A., & Stabile, L. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020611 · Cited by 202
Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes
Supek, F., & Lehner, B. (2017) · Cell · doi:10.1016/j.cell.2017.07.003 · Cited by 192
Champiat, S., Ferté, C., Lebel‐Binay, S., Eggermont, A. M. M., & Soria, J. (2014) · OncoImmunology · doi:10.4161/onci.27817 · Cited by 195
The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
Ma, J., Setton, J. S., Lee, N. Y., Riaz, N., & Powell, S. N. (2018) · Nature Communications · doi:10.1038/s41467-018-05228-y · Cited by 203
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
Chin, R.-I., Chen, K., Usmani, A., Chua, C., Harris, P. K., Binkley, M. S., Azad, T. D., Dudley, J. C., & Chaudhuri, A. A. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00390-5 · Cited by 191
The helicase domain of Polθ counteracts RPA to promote alt-NHEJ
Mateos‐Gómez, P. A., Kent, T., Deng, S., McDevitt, S., Kashkina, E., Hoàng, T., Pomerantz, R. T., & Sfeir, A. J. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3494 · Cited by 191
IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
Jaspers, J. E., Khan, J. F., Godfrey, W. D., Lopez, A. V., Ciampricotti, M., Rudin, C. M., & Brentjens, R. J. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166028 · Cited by 191
Variation in genomic landscape of clear cell renal cell carcinoma across Europe
Scélo, G., Riazalhosseini, Y., Greger, L., Létourneau, L., Gonzàlez-Porta, M., Wozniak, M. B., Bourgey, M., Harnden, P., Egevad, L., Jackson, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6135 · Cited by 195
Melanoma: What do all the mutations mean?
Davis, E. J., Johnson, D. B., Sosman, J. A., & Chandra, S. (2018) · Cancer · doi:10.1002/cncr.31345 · Cited by 197
Genoud, V., Marinari, E., Nikolaev, S. I., Castle, J. C., Bukur, V., Dietrich, P., Okada, H., & Walker, P. R. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1501137 · Cited by 190
The whole-genome landscape of Burkitt lymphoma subtypes
Panea, R., Love, C., Shingleton, J. R., Reddy, A., Bailey, J. A., Moormann, A. M., Otieno, J. A., Ong’echa, J. M., Oduor, C. I., Schroeder, K., et al. (2019) · Blood · doi:10.1182/blood.2019001880 · Cited by 194
Genomic heterogeneity of multiple synchronous lung cancer
Liu, Y., Zhang, J. J., Lin, L., Yin, G., Zhang, J., Zheng, S., Beird, H. C., Wu, N., Lü, N., Mao, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms13200 · Cited by 189
Metadata
- Authors
- Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., Bignell, G. R., Bolli, N., Borg, A., Børresen-Dale, A.-L., Boyault, S., Burkhardt, B., Butler, A. P., Caldas, C., Davies, H. R., Desmedt, C., Eils, R., Eyfjörd, J. E., Foekens, J. A., Greaves, M., Hosoda, F., Hutter, B., Ilicic, T., Imbeaud, S., Imielinski, M., Jäger, N., Jones, D. T. W., Jones, D., Knappskog, S., Kool, M., Lakhani, S. R., López-Otín, C., Martin, S., Munshi, N. C., Nakamura, H., Northcott, P. A., Pajic, M., Papaemmanuil, E., Paradiso, A., Pearson, J. V., Puente, X. S., Raine, K., Ramakrishna, M., Richardson, A. L., Richter, J., Rosenstiel, P., Schlesner, M., Schumacher, T. N., Span, P. N., Teague, J. W., Totoki, Y., Tutt, A. N. J., Valdés-Mas, R., van Buuren, M. M., van ’t Veer, L., Vincent-Salomon, A., Waddell, N., Yates, L. R., Zucman-Rossi, J., Andrew Futreal, P., McDermott, U., Lichter, P., Meyerson, M., Grimmond, S. M., Siebert, R., Campo, E., Shibata, T., Pfister, S. M., Campbell, P. J., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- BC Cancer Agency (CA)
- University of Cambridge (GB)
- Garvan Institute of Medical Research (AU)
- Lund University (SE)
- Oslo University Hospital (NO)
- Justus-Liebig-Universität Gießen (DE)
- Université Libre de Bruxelles (BE)
- German Cancer Research Center (DE)
- Erasmus MC Cancer Institute (NL)
- Inserm (FR)
- Broad Institute (US)
- The University of Queensland (AU)
- Universidad de Oviedo (ES)
- Harvard University (US)
- National Cancer Center Research Institute (JP)
- University of Glasgow (GB)
- Brigham and Women's Hospital (US)
- The Netherlands Cancer Institute (NL)
- Radboud University Medical Center (NL)
- King's College London (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Stratton, Michael R.
- ORCID
- Alexandrov, Ludmil B.
- Wedge, David C.
- Aparicio, Samuel A. J. R.
- Behjati, Sam
- Biankin, Andrew V.
- Bolli, Niccolò
- Boyault, Sandrine
- Burkhardt, Birgit
- Caldas, Carlos
- Davies, Helen R.
- Desmedt, Christine
- Eils, Roland
- Hutter, Barbara
- Imbeaud, Sandrine
- Imielinski, Marcin
- Jäger, Natalie
- Knappskog, Stian
- Kool, Marcel
- Lakhani, Sunil R.
- Martin, Sancha
- Munshi, Nikhil C.
- Nakamura, Hiromi
- Northcott, Paul A.
- Pajic, Marina
- Papaemmanuil, Elli
- Paradiso, Angelo
- Pearson, John V.
- Raine, Keiran
- Ramakrishna, Manasa
- Richardson, Andrea L.
- Richter, Julia
- Rosenstiel, Philip
- Schlesner, Matthias
- Schumacher, Ton N.
- Span, Paul N.
- Teague, Jon W.
- Totoki, Yasushi
- Tutt, Andrew N. J.
- Waddell, Nicola
- Yates, Lucy R.
- McDermott, Ultan
- Meyerson, Matthew
- Grimmond, Sean M.
- Siebert, Reiner
- Shibata, Tatsuhiro
- Pfister, Stefan M.
- Campbell, Peter J.
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2013-08-14
- Volume
- 500
- Issue
- 7463
- Pages
- 415-421
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3776390
- OpenAlex
- W2152061559
- Cited by
- 9,660
- References
- 67
- Citations by year
- 2026: 384 · 2025: 552 · 2024: 643 · 2023: 854 · 2022: 921 · 2021: 1119 · 2020: 1130 · 2019: 939 · 2018: 873 · 2017: 815 · 2016: 660 · 2015: 421 · 2014: 286 · 2013: 45
- FWCI
- 165.61
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-10-09)
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Consultation of the Doctoral Thesis Database (TESEO) (Ministerio de Educación, Cultura y Deporte) (submittedVersion, cc-by-nc-nd)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Deutsches Krebsforschungszentrum (69120)
- Wellcome Trust (088340, 093867, 098051)
- Broad Institute
- Canada's Michael Smith Genome Sciences Centre
- Cancer Research UK
- University of Glasgow
- Agence Nationale de la Recherche (ANR-10-LABX-0015)
- Institut National de la Santé et de la Recherche Médicale
- University of New South Wales
- Lunds Universitet
- Universitetet i Oslo
- Háskóli Íslands
- Universitat de Barcelona
- BC Cancer Agency
- Labex Immuno-Oncology
- Medisinske fakultet, Universitetet i Oslo
- Cancer Research UK Cambridge Institute, University of Cambridge
- National Cancer Institute (T32CA009216)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- mutational signatures, somatic mutations, cancer genome, APOBEC cytidine deaminases, kataegis, hypermutation, patient age, cancer etiology, cancer types
- MeSH terms
- Aging, Algorithms, Cell Transformation, Neoplastic, Cytidine Deaminase, DNA, DNA Mutational Analysis, Humans, Models, Genetic, Mutagens, Mutation, Neoplasms, Organ Specificity, Transcription, Genetic, Reproducibility of Results, Mutagenesis, Insertional, Mutagenesis, Sequence Deletion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
